Biopsy Devices Market Research Revealing the Growth Rate and Business Opportunities till 2027
The recent study of reports and data suggests that the Biopsy Devices Market is expected to attain a market value of USD 1.51 Billion by 2027 the end the forecast frame registering a CAGR of 10.8%. Breast Biopsy refers to a diagnostic procedure to determine whether a small sample removed from the breast tissue is cancerous. It is regarded as the most effective methods for cancer diagnosis. It is found that about 70-80% of the biopsies are negative of cancer, but may diagnose conditions that are predispose to mammary carcinoma. Breast biopsy is recommended when a person is facing symptoms like a breast lump, sore breast, breast dimpling, peel appearance to breast and nipple discharge etc. The invasive surgical methods for breast biopsy has been found to be disadvantageous as it is painful and the patient will have to bear the psychological stress of false positive referrals.
Get
a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2022
The increasing vulnerability of women to mammary
carcinoma in all the economies, along with the awareness drives and screenings
conducted in favor of women have propelled the demand side of the breast biopsy
market. The extensive and exhaustive research environment acts as an impetus to
the market which has aided in evolving more accurate and minimally invasive
methods for the early diagnosis of mammary carcinoma. The governments have also
worked towards building a continuous and comprehensive environment for cancer
research which has fueled the growth of these diagnostic devices. Also
favorable reimbursements in this regard has improved the state of this market
drastically. The growth of these diagnostic devices are impeded by the
prevalence of side effects and infections after the biopsy. Stringent
regulations by the USFDA and other notifying authorities along with high cost
of these services have worked against the unrestricted growth of the market.
Competitive Outlook:
This section of
the report performs a thorough investigation into the intensely competitive
landscape of the global Biopsy Devices market, highlighting the leading manufacturers,
strategic initiatives adopted by them, the existing growth prospects, market
positions, and market shares held by each participant. The report further emphasizes the
developmental strategies undertaken by these companies, including product innovation,
new product launches, and technological upgradation. Moreover, the report
studies the notable business events observed in this industry, such as mergers
& acquisitions, joint ventures, partnerships, corporate deals, and brand
promotions.
Leading
companies operating in the market and profiled in the report include:
· Becton,
Dickinson and Company
· C.R.
Bard, Inc
· Devicor
Medical Products Inc
· Hologic
Inc
· Argon
Medical Devices
· Cook
Medical Incorporated
· Encapsule
Medical Devices LLC
· Planmed
OY
· Ethicon
Endo Surgery (Johnson and Johnson)
Download Summary @ https://www.reportsanddata.com/download-summary-form/2022
Further Key Finding from the report
- The
mammary carcinoma is found to be the most common invasive cancer among
women and affects women in both developed and developing countries. Hence
the target consumers for breast biopsy is women above the age of 40. The
growing awareness of breast cancer has fueled the demand for this market
- The
American Cancer society has confirmed that there has been a decline in
deaths caused by breast cancer reason being that cancer have been detected
earlier through mammography, making it the most effective screening method
- Thermography
was popularized as it was a method to produce infrared images of head and
blood flow near the surface of the body, but it was found that it lacked
the ability to detect cancer at the early stage
- Advancements
and innovations are carried out in the product segment. Stryker, an
innovator in the given field have brought in PreciseCore needles which
have been used for improved precision and minimal tissue damage.
- Asia-Pacific
regional segment of the breast biopsy market is expected to remain highest
growing segment during 2019-2026, at a CAGR of 12.1%; owing it to increase
in medical awareness and untapped opportunities in India and China due to
rising pool of vulnerable geriatric women with awareness about mammary
carcinoma. However, conventional methods like surgery and needle rule the
market.
- Currently
the vacuum assisted breast biopsy has dominated over the market and is the
fastest growing segment as it overcomes the drawbacks of the conventional
needle based methods which is inherently characterized with inaccuracy. It
is growing at a CAGR of 10.9%.
- Key
players involve themselves in the innovative product launch, market
expansions and strategic acquisitions to capitalize their market share
- As
far as end users are concerned, hospitals are the second largest market
share holder. This can be attributed to the availability of highly skilled
personnel and favorable reimbursements
- Ultra
sound breast biopsy is considered to be the fastest growing as far as
guidance of imaging is concerned. This is due to the accuracy in imaging
and the lack of discomfort occurred during biopsy being non-invasive
Request
a customization of the report @ https://www.reportsanddata.com/request-customization-form/2022
Segments covered in the report:
This report forecasts revenue growth at a global,
regional & country level, and provides an analysis of the market trends in
each of the sub-segments from 2016 to 2026. For the purpose of this study,
Reports and Data have segmented the Breast Biopsy market on the basis of Type,
product, guidance, end use and regional outlook
Type (Revenue, USD Million; 2017–2027)
- Needle
Breast Biopsy
- Vacuum
Assisted Surgery
- Core
needle Biopsy
- Fine
Needle Aspiration Biopsy
- Open
Surgical Breast Biopsy
- Incisional
- Excisional
Product (Revenue, USD Million; 2017–2027)
- Biopsy
Needles
- Biopsy
Tables
- Guidance
Systems
- Localization
Wires
- Punches
- Markers
- Sutures
Guidance Type (Revenue, USD Million;
2017–2027)
- Mammography
- Ultra
sound
- MRI
- CT
scan
- Others
End Use (Revenue, USD Million; 2017–2027)
- Diagnostic
Clinic
- Hospitals
- Others
Regional Outlook (Revenue in USD Million;
2017–2027)
- North
America
- Europe
- Asia
Pacific
- Middle
East & Africa
- Latin
America
Get
TOC of this Report @ https://www.reportsanddata.com/report-detail/breast-biopsy-device-market/toc
Key
Benefits of Buying the Global Biopsy Devices Report:
· Comprehensive
analysis of the changing competitive landscape
· Assists
in decision making processes for the businesses along with detailed strategic
planning methodologies
· The
report offers an 8-year forecast and assessment of the Global Biopsy Devices
Market
· Helps
in understanding the key product segments and their estimated growth rate
· In-depth
analysis of market drivers, restraints, trends, and opportunities
· Comprehensive
regional analysis of the Global Biopsy Devices Market
· Extensive
profiling of the key stakeholders of the business sphere
·
Detailed analysis of the factors
influencing the growth of the Global Biopsy Devices Market
Read
Our More Reports
X-ray
Detectors Market Size, Share & Analysis, By Type (Amorphous Silicon
(TFT), CMOS, Others), By Application (Medical, Dental, Security, Veterinary,
Industrial, Other) And Region- Global Forecasts To 2028
Phototherapy
Market Analysis, By Therapy Type (Ultraviolet B, Psoralen UV A) By Disease
Type (Skin Diseases, Cancers and Pre-cancers, Neonatal Jaundice, Mood and Sleep
Disorders) By Device Type (CFL, LED, Lamps) By End Use (Home, Clinic,
Hospital), Forecasts To 2028
About Us:
Reports and Data is a market research and consulting
company that provides syndicated research reports, customized research reports,
and consulting services. Our solutions purely focus on your purpose to locate,
target and analyze consumer behavior shifts across demographics, across
industries and help client’s make a smarter business decision. We offer market
intelligence studies ensuring relevant and fact-based research across a
multiple industries including Healthcare, Technology, Chemicals, Power and
Energy. We consistently update our research offerings to ensure our clients are
aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Comments
Post a Comment